Skip to menu Skip to content Skip to footer

A universal 'correct and select' gene therapy platform to cure monogenic blood and immune diseases (MRFF SCT administered by WEHI) (2026-2031)

Experts

Associate Professor Seth Cheetham

Affiliate of ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR)
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Australian Institute for Bioengineering and Nanotechnology
Director, National Biologics Facility and AIBN Group Leader
Australian Institute for Bioengineering and Nanotechnology
Seth Cheetham
Seth Cheetham